ReNetX Bio Launched to Advance Innovative Neuro-Regenerative Technology Developed at Yale University Company Appoints Erika R. Smith as CEO; Previously Director at Yale Innovation Fund Initiates Series A Financing Round to Fund Clinical Trial in Chronic Spinal Cord Injury NEW HAVEN, Conn., July ...